In some cases, GoodRx used the information to target people with health-related ads." The alert comes a month after the FTC announced a formal settlement with the digital health platform and ...
On February 1, 2023, the U.S. Federal Trade Commission (FTC) filed a proposed order implementing a permanent injunction and civil penalties against GoodRx in what the FTC called a “first-of ...
The Federal Trade Commission said it is expecting to look into more telehealth startups who are sharing consumer data with third parties, The Wall Street Journal reported March 26.
The Federal Trade Commission (FTC) recently kicked off enforcement of its Health Breach Notification Rule (Breach Rule) by taking aim at GoodRx’s use of tracking technologies (e.g. pixels ...
The Federal Trade Commission's recent actions against two companies in separate health data privacy cases are significant ...
February 27, 2023 - The Department of Justice (DOJ) and the Federal Trade Commission (FTC) have officially resolved allegations against GoodRx surrounding violations of the FTC Act and the Health ...
In a civil injunction filed Feb. 1, the FTC said it found people who used GoodRX between the years of 2017 and 2020 had their private, sensitive health information sold to third party advertisers ...
Since 2020, the FTC has taken several actions to protect consumer health data collected online and in apps. In addition to GoodRx, the agency brought cases against period tracking app Flo Health ...
The rule requires entities to report any breaches of consumer health information to the FTC. But until the GoodRx decision, the agency had yet to use its authority to penalize violations.
Prescription drug discounter GoodRx, which began February by agreeing ... nor 12 financial analysts asking questions brought up the FTC fine in particular or privacy issues in general.
GoodRx recently paid $1.5 million in a settlement to the Federal Trade Commission because it allegedly was sharing health information with third parties. The FTC also prohibited GoodRx from ...
